News
PredictCan Extends Its Cell Educating Technology™ to Pancreatic Cancer
A new study published in Translational Oncology, in collaboration with clinicians from Montpellier University Hospital, demonstrates the application of PredictCan’s patient-educated models to pancreatic cancer and their ability to reflect individual clinical treatment responses.
PredictCan Selected as a Boost Invest MedVallée Awardee
PredictCan Biotechnologies has been selected as a Boost Invest MedVallée awardee, recognizing the company’s scientific achievements, international development, and strategy for its next phase of growth.
PredictCan Named Among Five Precision Medicine Startups to Watch Worldwide
PredictCan Biotechnologies has been selected by StartUs Insights as one of five exemplary precision medicine startups, following the analysis of more than 600 companies worldwide.
PredictCan’s HCC Models Predict Individual Clinical Response to Anticancer Therapies
Published in Scientific Reports, PredictCan’s patient-centric HCC models correctly predicted 34 out of 37 clinical treatment outcomes, demonstrating the potential of combining human biological diversity with the TICK exclusion strategy for preclinical anticancer drug evaluation.
Official collaboration between PredictCan Biotechnologies and PRADO, Preclinical Research and Development Organization to develop alternative solutions to animal testing.
Animal testing plays a critical role in gaining important knowledge needed to thoroughly evaluate the products towards reducing the health risks and sufferings to human and animals. The current regulatory framework of various countries and FDA permits, encourages, and supports the use of new alternative methods to animal testing that
PredictCan members attended the EUROTOX 2024 in Copenhagen
Our CEO Dr Hong Tuan DUONG, discussed the use of individual-centric spheroid model to decipher the initiating-mechanism of immune mediated idiosyncratic drug-induced liver injury by presenting the poster “Dissecting the idiosyncratic drug-induced liver injury (iDILI)-initiating mechanism using the individual-centric model: the role of the innate immune response” While Dr Sara